Retrospective study of complete remission imatinib-free metastatic gastro-intestinal stromal tumors (GIST).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e23512
Abstract: e23512Background: Imatinib (IM) treatment should be continued indefinitely in advanced GIST since treatment interruption is generally followed by rapid tumor progression in almost all cases, even w... read more here.
Keywords: study complete; complete remission; remission imatinib; imatinib free ... See more keywords